Henry Sacks, MD, PhD
- PROFESSOR | Geriatrics and Palliative Medicine
- PROFESSOR | Medicine, Infectious Diseases
- PROFESSOR | Oncological Sciences
- PROFESSOR | Biomathematical Sciences
- PROFESSOR | Pediatrics
Dr. Sacks is the Director of the Thomas C. Chalmers Clinical Trials Unit.
American Board of Internal Medicine
Multi-Disciplinary Training AreasClinical Research Education Program [CLR], Public Health [PH]
PhD, Albany Medical College
MD, Albany Medical College
Internship, General Medicine, University of Connecticut
Residency, Internal Medicine, University of Connecticut
Fellowship, Infectious Diseases, University of Connecticut
Dr. Sacks originally came to Mount Sinai to work with Thomas C. Chalmers, a pioneer in what is now called "evidence-based medicine." His work has been in two categories: 1) the design, conduct and analysis of clinical and natural history studies (primary studies), to provide new data to directly answer clinical questions, and 2) synthesis of existing data by meta-analysis, decision analysis and cost-effectiveness analysis, to provide guidance for urgent clinical problems for which primary data are not (or not yet) available. Dr. Sacks' current research interests include clinical trials, infections in the elderly, HIV, complementary and alternative therapies.
Dr. Sacks is also Director for Clinical Research of Mount Sinai's Complementary and Alternative Medicine (CAM) Center, and co-director of Mount Sinai's Fogarty International AIDS Training program.
- Effects of a dietary supplement (SV) on advanced non small cell lung cancer patients treated with best supportive care (BSC): A randomized double-blind placebo controlled study, a phase III Trial
The purpose of this study is to evaluate the effects of a dietary supplement called “Selected Vegetable Herb Mix (SV)” in advanced Non-Small Cell Lung Cancer (NSCLC) patients receiving standard chemotherapy.
You may qualify because you have been diagnosed with non-sm...
Dunn AS, Wisnivesky J, Ho W, Moore C, Mcginn T, Sacks HS. Perioperative management of patients on oral anticoagulants: a decision analysis. Med Decis Making 2005 Jul-Aug;: 387-397.
Rovetto AL, Lai CY, Sacks H. Cost-Effectiveness of Probiotic Treatment in Preventing Hospital-Acquired Clostridium Difficile-Associated Diarrhea.;.